Ian Sample

Presenter, The Guardian · Presenter · Science editor, The Guardian

Titles as the sources gave them. In 5 entries, with 0 checked quotations.

In the Base

Every entry they appear in.

  1. PodcastThe GuardianSpeaks

    ‘These risks are real’: the threat of AI bioweapons – podcast

    According to the description, Ian Sample speaks with Dr Tom Inglesby of the Johns Hopkins Center for Health Security about why governments worry that AI could change the stakes for bioweapons, following a warning in the MI5 director general's annual threat speech, and what measures could reduce the risk.

  2. VideoThe GuardianSpeaks

    ‘These risks are real’: the threat of AI bioweapons - video

    According to the description, Ian Sample speaks to Dr Tom Inglesby of the Johns Hopkins Center for Health Security about why governments worry that AI could change the stakes on bioweapons, after a speech by MI5's head Sir Ken McCallum, and what could reduce the risk.

  3. VideoThe GuardianSpeaks

    Is your boss watching you? The rise of AI surveillance at work - video

    According to the description, Ian Sample talks with the Guardian's UK technology editor Robert Booth about AI systems that give employers minute-by-minute accounts of worker activity and productivity, which sectors are adopting them, why, and how the approach could backfire.

  4. PodcastThe Guardian (Science Weekly)Speaks

    Is your boss watching you? The rise of AI surveillance at work – podcast

    According to the episode description, Ian Sample talks to Guardian UK technology editor Robert Booth about AI-based workplace monitoring that builds minute-by-minute accounts of activity and productivity, which sectors adopt it, why, and how it could backfire. We could not read the audio.

  5. NewsThe GuardianWrote it

    Could AI ‘change the stakes’ in the development of bioweapons?

    The Guardian's science editor explains, after the MI5 chief's warning, how AI might help terrorists and states build bioweapons. Experts quoted say AI mainly amplifies existing expertise, while materials, tacit know-how and facilities remain barriers. One expert calls for independent pre-release evaluations and restricted biological data.